In this episode, Dr. Brittany Weber discusses the role of inflammation and hsCRP in cardiovascular disease, focusing on their connection to atherosclerosis, immune activation, endothelial damage, and the impact of systemic inflammatory diseases on cardiovascular risk. Tune in to learn about the mechanisms behind inflammation in cardiovascular disease and the significance of hsCRP as a biomarker.

In this episode, Dr. Paul Ridker explores the crucial role of inflammation and high-sensitivity CRP (hsCRP) in cardiovascular health. Tune in to gain a deeper understanding of how hsCRP can be a powerful tool in predicting and managing cardiovascular health.

In this episode, Dr. Michael Garshick discusses the role of pharmacologic interventions in managing inflammation and high-sensitivity CRP (hsCRP) in cardiovascular (CV) disease. Watch now to learn about the latest advancements in pharmacologic strategies for reducing cardiovascular risk through inflammation management.

In this episode, Dr. Brendan Everett discusses how lifestyle changes can reduce low-grade systemic inflammation. Watch now to learn how lifestyle interventions can play a crucial role in reducing inflammation and improving cardiovascular health.

In this episode, Dr. Amir Rezvan hosts a panel discussion with distinguished colleagues Dr. Paul Ridker, Dr. Brendan Everett, Dr. Michael Garshick, and Dr. Kaitlin Voigts Key. Tune in for this insightful discussion on the importance of hsCRP in preventive cardiology and how to effectively use this biomarker in clinical practice.

In this episode Dr. Paul Ridker discusses the pivotal role of high-sensitivity C-reactive protein (hsCRP), a biomarker for inflammation, in cardiovascular prevention and treatment. He explains how inflammation and cholesterol together drive atherosclerosis, the significance of hsCRP testing, and the latest clinical trial findings.